Ekso Bionics Soars After Spinoff Merger
Update: 2026-01-01
Description
Ekso Bionics stock surged nearly 100% on December 30th following Applied Digitals announcement to spin off its cloud segment and merge with Ekso Bionics to form ChronoScale. This merger aims to unlock value in Applied Digitals businesses and boost Ekso Bionics shareholder returns. Despite the excitement, Ekso stock is still down 40% from its year-to-date high. The company specializes in robotic exoskeletons for rehab and workplace safety, with revenue jumping 105% from the prior quarter. Technicals look strong, with shares trading above key moving averages and momentum holding. Wall Street rates it a moderate buy, but the stock now trades above the average price target, suggesting a near-term pullback. However, for long-term investors, Ekso could be worth watching in 2026. Checkout Solipillow.com
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
